Barclays PLC Has $1.83 Million Stake in Transcat, Inc. (NASDAQ:TRNS)

Barclays PLC increased its position in Transcat, Inc. (NASDAQ:TRNS) by 393.0% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 15,130 shares of the scientific and technical instruments company’s stock after buying an additional 12,061 shares during the period. Barclays PLC’s holdings in Transcat were worth $1,826,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Conestoga Capital Advisors LLC boosted its position in shares of Transcat by 17.9% in the third quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock valued at $109,561,000 after acquiring an additional 137,830 shares during the period. Champlain Investment Partners LLC lifted its position in shares of Transcat by 22.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock worth $49,455,000 after buying an additional 74,169 shares during the period. Royce & Associates LP lifted its holdings in Transcat by 8.2% during the 3rd quarter. Royce & Associates LP now owns 511,701 shares of the scientific and technical instruments company’s stock valued at $61,798,000 after purchasing an additional 38,774 shares during the last quarter. Hood River Capital Management LLC raised its position in Transcat by 21.6% in the 2nd quarter. Hood River Capital Management LLC now owns 196,838 shares of the scientific and technical instruments company’s stock valued at $23,558,000 after purchasing an additional 34,947 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its holdings in Transcat by 28.8% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company’s stock worth $9,577,000 after acquiring an additional 17,743 shares during the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on TRNS shares. Northland Securities decreased their price target on Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a report on Wednesday, October 30th. HC Wainwright reissued a “buy” rating and set a $156.00 price target on shares of Transcat in a research report on Tuesday, October 29th. Oppenheimer restated an “outperform” rating and issued a $130.00 price objective (down previously from $155.00) on shares of Transcat in a research report on Wednesday, October 30th. Craig Hallum raised their price objective on Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Finally, StockNews.com cut shares of Transcat from a “hold” rating to a “sell” rating in a report on Tuesday, October 29th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $130.25.

Transcat Stock Down 1.8 %

NASDAQ TRNS opened at $106.01 on Friday. Transcat, Inc. has a 12-month low of $94.29 and a 12-month high of $147.12. The firm’s 50 day moving average is $107.62 and its 200-day moving average is $118.04. The company has a market capitalization of $975.19 million, a PE ratio of 53.54 and a beta of 0.70.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.12). The company had revenue of $67.83 million during the quarter, compared to the consensus estimate of $70.30 million. Transcat had a net margin of 6.63% and a return on equity of 7.36%. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.41 earnings per share. As a group, sell-side analysts expect that Transcat, Inc. will post 1.76 EPS for the current year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.